This concept was initially proposed by Dr
GLP-1 Receptor Agonists: Single Agonists in Obesity Treatment Role of GLP-1 in Energy and Glucose Homeostasis Glucose-dependent insulinotropic polypeptide (GIP) is an incretin hormone secreted by enteroendocrine K cells in the proximal small intestine in response to nutrient ingestion
Disorders of CPT1B, the muscle isoform, and CPT1C, the neuronal isoform, have not been reported in humans yet
Catalpol ameliorates depressive-like behaviors in CUMS mice via oxidative stress-mediated NLRP3 inflammasome and neuroinflammation
dose reduction of concomitant medications may be necessary Diabetic retinopathy: Rapid improvement in glycemic control has been associated with temporary worsening of diabetic retinopathy in some diabetes trials Acute kidney injury: Cases have been reported, often in the setting of volume depletion from gastrointestinal adverse effects Gallbladder disease: Risk of cholelithiasis and cholecystitis may be increased Hypersensitivity reactions: Including anaphylaxis and angioedema have been reported Not recommended: In patients with severe gastrointestinal disease, including severe gastroparesis Additional important counseling points: Pregnancy: Zepbound should not be used for weight management during pregnancy
Off the 60 patients who had been commenced on this therapy, no dropouts were seen, indicating that this therapy would be quite well accepted if the patients were chosen and counseled properly
